Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Dent Mater J ; 40(6): 1403-1409, 2021 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-34261832

RESUMO

To establish optimal elastic modulus distribution throughout the entire all-ceramic crown, aiming at improvement of the mechanical properties of the restoration as well as the adhesive interface, seven 3D models of mandibular first premolars of zirconia monolithic and bilayer crowns and lithium disilicate monolithic and bilayer crowns were constructed. The elastic modulus distribution of 8-layer crown A referred to human enamel, B was calculated by a genetic algorithm (GA) to minimize the principle stresses on the crown, and C minimized the shear stresses at the cementing lines. After applying a static load of 600 N, the maximum principle stresses were calculated and analyzed by finite element analysis (FEA). Group C were found to have the lowest peak shear stress at the cementing line and moderate peak tensile stress in the crown. Introduction of the modified elastic modulus distribution from human enamel into the entire all-ceramic crown reinforces the mechanical properties of the whole restoration as well as the adhesive interface against chipping and debonding.


Assuntos
Coroas , Porcelana Dentária , Dente Pré-Molar , Análise do Estresse Dentário , Módulo de Elasticidade , Análise de Elementos Finitos , Humanos , Teste de Materiais
2.
Int J Biol Macromol ; 162: 262-272, 2020 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-32569688

RESUMO

The nano drug delivery system (NDDS) has been extensively investigated for cancer treatment because of its ability to enhance drug efficacy. However, there are only a few studies attempting NDDS for AZD9291 (Osimertinib). Here, we encapsulated AZD9291 in chitooligosaccharides (COS)-modified poly (lactic-co-glycolic acid) (PLGA) nanoparticles. COS, a cationic polymer, was used to develop positively charged nanoparticles with good biological affinity. The prepared AZD-PLGA-COS NPs exhibited a smaller particle size (176.6 ± 0.4 nm), a positively charged surface (+18.65 ± 0.38 mV), and an increased cellular uptake. The IC50 of H1975 cells was reduced by 45.90%, and the expression of p-EGFR, PARP, Bak, caspase-9, Bax, and Bcl-2 was regulated to promote cellular apoptosis. Furthermore, COS was found to inhibit the expression of immune checkpoint PD-L1. This study suggests that COS-modified PLGA nanoparticles with low toxicity and high encapsulation efficiency (EE) could potentially enhance drug efficacy.


Assuntos
Acrilamidas/farmacologia , Compostos de Anilina/farmacologia , Antineoplásicos/farmacologia , Apoptose/efeitos dos fármacos , Quitina/análogos & derivados , Portadores de Fármacos/química , Nanopartículas/química , Copolímero de Ácido Poliláctico e Ácido Poliglicólico/química , Antígeno B7-H1/metabolismo , Caspase 9/metabolismo , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Quitina/química , Quitosana , Liberação Controlada de Fármacos , Receptores ErbB/metabolismo , Humanos , Concentração Inibidora 50 , Microscopia Eletrônica de Transmissão , Nanopartículas/toxicidade , Nanopartículas/ultraestrutura , Oligossacarídeos , Tamanho da Partícula , Poli(ADP-Ribose) Polimerase-1/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Proteína Killer-Antagonista Homóloga a bcl-2/metabolismo , Proteína X Associada a bcl-2/metabolismo
3.
China CDC Wkly ; 2(11): 167-171, 2020 Mar 14.
Artigo em Inglês | MEDLINE | ID: mdl-34594617

RESUMO

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC?: Enterovirus 71 (EV-A71) is the main causative pathogen for severe and fatal patients with Hand, Foot, and Mouth Disease (HFMD) in mainland China from 2008 to 2017. Non-EV-A71 and non-CV-A16 (other enterovirus) serotypes were the major causative-serotypes for mild HFMD in years of 2013, 2015, and 2017. WHAT IS ADDED BY THIS REPORT?: In 2018, other enterovirus serotypes replaced EV-A71 for the first time as the major cause of severe HFMD with a proportion of 70.7%. However, at the national level, only a small proportion of the other enterovirus serotypes were further identified as CV-A6 and CV-A10. WHAT ARE THE LIMITATIONS FOR PUBLIC HEALTH PRACTICE?: Further identification of other enterovirus serotypes is highly recommended for provincial CDCs, especially for severe HFMD. Studies contributing to a multivalent vaccine for HFMD should be prioritized.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA